Novartis | NVS - 보통주 자본

주가
154.86
매일 변경
0.65 0.42%
매월
-6.71%
매년
41.87%
Q1 예상
149.59




보통주 자본 변화 날짜
AbbVie USD 1.77B 1.75B 2025-06
Amgen USD 539M 1000K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Bausch Health Companies USD 370.53M 59K 2025-12
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 332.38M 127.23M 2025-09
Corcept Therapeutics USD 105.97M 842K 2025-12
Drreddys Laboratories INR 832.57M 53K 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Gilead Sciences USD 1.24B 1000K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Glaxosmithkline GBP 4.03B 2.68B 2025-09
J&J USD 2.41B 584K 2025-09
Merck USD 2.49B 15.79M 2025-09
Novartis USD 1.94B 23.4M 2025-06
Novartis USD 1.92B 17.06M 2025-09
Pacira USD 41.12M 1.85M 2025-12
Perrigo USD 137.6M 0 2025-12
Pfizer USD 5.69B 1000K 2025-09
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 48.08M 47.52M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
Zoetis USD 424.93M 16.54M 2025-12